Alaunos Therapeutics, Inc.

TCRTCIK 0001107421 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0019

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 26, 20268.01 · Other Events9.01 · Financial Statements and Exhibits May 18, 2026no items parsed Apr 15, 2026no items parsed Mar 2, 2026no items parsed Jan 8, 2026no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Alaunos Therapeutics, Inc.

Name	Roles	Filings
Postma Robert W	Director	10
Vieser Jaime	Director	10
Weis Holger	OfficerDirector	7
Jerman Michael Allen	Director	4
Boyle Kevin S. Sr.	OfficerDirector	3

Showing 1-5 of 16

Per pagePage 1 of 4Next

All filings

57 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
May 27, 2026	Weis Holger Chief Executive Officer	AGrant	3,700	$2.37	$8,769
May 1, 2026	Jerman Michael Allen Director	AGrant	6,032	$2.59	$15,623
May 1, 2026	Postma Robert W Director	AGrant	6,274	$2.59	$16,250
May 1, 2026	Vieser Jaime Director	AGrant	6,515	$2.59	$16,874
Jan 15, 2026	Vieser Jaime Director	AGrant	5,839	$2.89	$16,875

Showing 1-5 of 57

Per pagePage 1 of 12Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value